Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma I: Introduction01:28

Asthma I: Introduction

88
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
88
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

38
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
38
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of artificial intelligence on magnetocardiology.

Clinical hemorheology and microcirculation·2026
Same author

GRASPion: An open-source, programmable brainbot for active matter research.

The Review of scientific instruments·2026
Same author

Multimodality assessment of aortic valve area in aortic stenosis: a multicenter validation study.

The international journal of cardiovascular imaging·2025
Same author

Dermal wipe sampling method development and validation for semivolatile and nonvolatile flame-retardant compounds TBBPA and TPP for use in occupational exposure assessments.

Journal of occupational and environmental hygiene·2025
Same author

The laminar organization of cell types in macaque cortex and its relationship to neuronal oscillations.

bioRxiv : the preprint server for biology·2024
Same author

Method for comparison of data driven gating algorithms in emission tomography.

Physics in medicine and biology·2023

Related Experiment Video

Updated: Apr 28, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.9K

Integrating asthma hazard characterization methods for consumer products.

A Maier1, M J Vincent2, B Gadagbui2

  • 1University of Cincinnati, 3223 Eden Avenue, Cincinnati, OH 45267, United States.

Regulatory Toxicology and Pharmacology : RTP
|June 18, 2014
PubMed
Summary
This summary is machine-generated.

Current methods struggle to link consumer products to asthma triggers. A new weight-of-evidence approach is needed to accurately assess respiratory hazards from everyday product ingredients.

Keywords:
AsthmaConsumer productsHazard characterization

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

34.4K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

17.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.9K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

34.4K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

17.2K

Area of Science:

  • Toxicology
  • Environmental Health
  • Respiratory Medicine

Background:

  • The link between asthma and consumer products is complex and not fully understood.
  • Existing occupational asthma data doesn't always translate to consumer exposure levels.
  • Current risk assessment methods fail to predict asthma triggers from consumer products.

Purpose of the Study:

  • To evaluate chemical hazard characterization methods for asthma and asthma-like responses.
  • To address the need for a system to characterize respiratory hazards from consumer products.
  • To develop a refined weight-of-evidence (WoE) approach for assessing consumer product-related asthma risks.

Main Methods:

  • Evaluation of existing chemical hazard characterization methods.
  • Analysis of data on asthma and asthma-like responses.
  • Consideration of assay relevance, potency, mode of action, and validation within a WoE framework.

Main Results:

  • Current methods are insufficient to definitively identify consumer product ingredients that cause or worsen asthma at low exposure levels.
  • Existing hazard characterization lacks the precision to predict respiratory sensitization from consumer products.
  • A need for hierarchical lines of evidence and improved assay validation was identified.

Conclusions:

  • A refined weight-of-evidence approach is necessary for better characterization of asthma hazards from consumer products.
  • Improved assay validation and organization by mode of action are crucial for accurate risk assessment.
  • Further development is needed to reliably assess the respiratory health impacts of consumer product ingredients.